Impact of clinical, pathologic, and treatment-related factors on outcome in patients with locally advanced breast cancer treated with multimodality therapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 22, Issue 2, 1999, Pages 119-125

  Victor, Sandra J ^a   Horwitz, Eric M ^a   Kini, Vijay R ^a   Martinez, Alvaro A ^a   Pettinga, Jane E ^a   Dmuchowski, Carl F ^a   Decker, David A ^a   Wilner, Freeman M ^a   Vicini, Frank A ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Breast carcinoma; Chemotherapy; Locally advanced breast cancer; Radiation therapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CARCINOMA; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; HUMAN; INFLAMMATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PARTIAL MASTECTOMY; TREATMENT OUTCOME;

ADULT; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; OUTCOME ASSESSMENT (HEALTH CARE); SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033512366     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199904000-00003     Document Type: Article

References (28)

1. Haagenson CD, Stout AP. Cancer of the breast II: criteria of operability. Ann Surg 1943;118:859-70.
2. Spanos WJ Jr, Montague ED, Fletcher GH. Late complications of radiation only for advanced breast cancer. Int J Radiat Oncol Biol Phys 1980;6:1473-6.
3. Bedwinick J, Rao DV, Ferez C, Lee J, Fineberg B. Stage III and localized stage IV breast cancer: irradiation alone vs irradiation plus surgery. Int J Radiat Oncol Biol Phys 1982;8:31-6.
4. Derman DP, Browde S, Kessel IL, et al. Adjuvant chemotherapy (CMF) for stage III breast cancer: a randomized trial. Int J Radiat Oncol Biol Phys 1989;17:257-61.
5. Klefstrom P, Grohn P, Heinonen E, Holsti L, Holsti P. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer, II: 5-year results and influence of levamisole. Cancer 1987;60:936-42.
6. Overgaard, M. The role of post-mastectomy radiotherapy in high-risk breast cancer patients receiving adjuvant systemic therapy. Fifth International Meeting of Progress in Radio-Oncology ICRO/ OGRO, 1995. Bologna, Italy: Monduzzi Editore, 1995;41-5.
7. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997;337:949-55.
8. Perez CA, Graham ML, Taylor ML, et al. Management of locally advanced carcinoma of the breast: noninflammatory. Cancer 1994; 74(suppl):453-65.
9. Ragaz J, Jackson S, Le N, et al. Can adjuvant local-regional therapy reduce systemic recurrences in stage I-II breast cancer patients? Recurrence analysis of the British Columbia Randomized Trial [Abstract]. Proceedings of the American Society of Clinical Oncology 1996;15:21.
10. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-62.
11. American Joint Committee on Cancer. Breast. In: Bearhrs OH, Henson DR, Mutter RVP, Kennedy BJ, eds. Manual for staging of cancer. 4th ed. Philadelphia: J B Lippincott, 1992,149-54.
12. Kaplan EL, Meier P. Nonparametric estimation for complete observations. Journal of the Royal Statistical Society A 1972;135: 185-207.
13. Mantel N, Haenszel W. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. Journal of the American Statistical Society 1963;58:690-700.
14. Simon R. Use of regression models: statistical aspects. In: Buyse M, Staqeut M, Sylvester R, eds. Cancer clinical trials: methods and practice. Oxford, UK: Oxford Medical Publications, 1984: 444-66.
15. Monyak D, Levitt SH. Breast: locally advanced (T3 and T4) and recurrent tumors. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology. 2nd ed. Philadelphia: J B Lippincott, 1992;948-69.
16. Gardin G, Rosso R, Campora E, et al. Locally advanced non-metastatic breast cancer: analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach. Eur J Cancer 1995;31:1428-33.
17. Pierce L, Lippman M, Ben-Baruch N, et al. The effect of systemic therapy on local-regional control in locally advanced breast caner. Int J Radiat Oncol Biol Phys 1992;23:949-60.
18. Fowble B, Gray R, Gilchrist K, Goodman RL, Taylor S, Tormey DC. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol 1988;6:1107-17.
19. Stefanik D, Goldberg R, Byrne P, et al. Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1985;3:660-5.
20. Griem KL, Henderson IC, Gelman R, et al. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol 1987;5:1546-55.
21. Bonadonna G, Valagussa P. Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 1981;304:10-5.
22. Fowble B, Goodman RL, Glick JH, Rosato EF, eds. Breast cancer treatment: a comprehensive guide to management. St. Louis: Mosby Year Book, 1991.
23. Sheldon T, Hayes DF, Cady B, et al. Primary radiation therapy for locally advanced breast cancer. Cancer 1987;60:1219-25.
24. Spangenberg JP, Nel CJC, Anderson ID, Doman MJ. A prospective study of the treatment of stage III breast cancer. S Afr J Surg 1986;24:57-60.
25. Velez-Garcia E, Carpenter JT Jr, Moore M, et al. Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a south-eastern cancer study group (SEG) trial. Eur J Cancer 1992;28A: 1833-7.
26. Arriagada R, Rutqvist LE, Mattsson A, Kramar A, Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination [see comments]. J Clin Oncol 1995; 13:2869-78.
27. Rutqvist LE, Pettersson D, Johansson H. Adjuvant radiation therapy versus surgery alone in operable breast cancer: long-term follow-up of a randomized clinical trial. Radiother Oncol 1993; 26:104-10.
28. Overgaard M, Christensen JJ, Johansen H, et al. Evaluation of radiotherapy in high-risk breast cancer patients: report from the Danish breast cancer cooperative group (DBCG 82) trial. Int J Radiat Oncol Biol Phys 1990;19:1121-4.